Risk assessment in pulmonary arterial hypertension

被引：27
|
作者：
Boucly, Athenais [1 ,2 ,3 ]
Weatherald, Jason [4 ]
Humbert, Marc [1 ,2 ,3 ]
Sitbon, Olivier [1 ,2 ,3 ]
机构：
[1] Univ Paris Saclay, Univ Paris Sud, Fac Med, Le Kremlin Bicetre, France
[2] Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France
[3] Hop Marie Lannelongue, INSERM UMR S 999, Le Plessis Robinson, France
[4] Univ Calgary, Div Respirol, Dept Med, Calgary, AB, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 51卷 / 03期
关键词：
D O I：
10.1183/13993003.00279-2018
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Risk assessment in pulmonary arterial hypertension
    Raina, Amresh
    Humbert, Marc
    [J]. EUROPEAN RESPIRATORY REVIEW, 2016, 25 (142): : 390 - 398
  • [2] Risk Assessment in Pulmonary Arterial Hypertension
    Hoeper, M.
    Pittrow, D.
    Opitz, C. F.
    Gibbs, J.
    Rosenkranz, S.
    Gruenig, E.
    Olsson, K.
    Huscher, D.
    Delcroix, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [3] Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Humbert, Marc
    Farber, Harrison W.
    Ghofrani, Hossein-Ardeschir
    Benza, Raymond L.
    Busse, Dennis
    Meier, Christian
    Hoeper, Marius M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (06)
  • [4] Validation of a risk assessment instrument for pulmonary arterial hypertension
    Weatherald, Jason
    Sitbon, Olivier
    Humbert, Marc
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 (47) : 4182 - 4185
  • [5] A Modified Risk Assessment Score for Pulmonary Arterial Hypertension
    Xiong, W.
    Xu, M.
    Wang, L.
    Guo, J.
    Liu, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Risk assessment in Scleroderma-associated pulmonary arterial hypertension
    Mercurio, Valentina
    Diab, Nermin
    Peloquin, Grace
    Housten-Harris, Traci
    Damico, Rachel
    Kolb, Todd M.
    Mathai, Stephen C.
    Hassoun, Paul M.
    [J]. VASCULAR PHARMACOLOGY, 2020, 132
  • [7] Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
    Boucly, Athenais
    Weatherald, Jason
    Savale, Laurent
    Jais, Xavier
    Cottin, Vincent
    Prevot, Gregoire
    Picard, Francois
    de Groote, Pascal
    Jevnikar, Mitja
    Bergot, Emmanuel
    Chaouat, Ari
    Chabanne, Celine
    Bourdin, Arnaud
    Parent, Florence
    Montani, David
    Simonneau, Gerald
    Humbert, Marc
    Sitbon, Olivier
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
  • [8] Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension
    Olsson, Karen M.
    Hoeper, Marius M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (04)
  • [9] Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment?
    Singh, Navneet
    Ventetuolo, Corey E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (09) : 988 - 990
  • [10] Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension
    Zelt, Jason G. E.
    Hossain, Alomgir
    Sun, Louise Y.
    Mehta, Sanjay
    Chandy, George
    Davies, Ross A.
    Contreras-Dominguez, Vladimir
    Dunne, Rosemary
    Doyle-Cox, Caroyln
    Wells, George
    Stewart, Duncan J.
    Mielniczuk, Lisa M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (07): : 675 - 685
12345